
Sign up to save your podcasts
Or


Frank Holland and the Investment Committee discuss if today’s jobs report gives the Fed the greenlight to resume raising rates. Plus, a strong first months for the semi stocks. The panel debates what’s ahead for the chips in the second half of the year. Bullish calls out on Ford, GM and Tesla. And, the Chart of the Day is Biogen, as it gets FDA approval for its Alzheimer’s treatment.
Investment Committee Disclosures
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
By CNBC4.5
338338 ratings
Frank Holland and the Investment Committee discuss if today’s jobs report gives the Fed the greenlight to resume raising rates. Plus, a strong first months for the semi stocks. The panel debates what’s ahead for the chips in the second half of the year. Bullish calls out on Ford, GM and Tesla. And, the Chart of the Day is Biogen, as it gets FDA approval for its Alzheimer’s treatment.
Investment Committee Disclosures
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

4,089 Listeners

3,224 Listeners

1,362 Listeners

240 Listeners

149 Listeners

322 Listeners

67 Listeners

154 Listeners

2,152 Listeners

2,112 Listeners

597 Listeners

560 Listeners

20 Listeners

301 Listeners

122 Listeners

315 Listeners

808 Listeners

180 Listeners

62 Listeners

162 Listeners

156 Listeners

34 Listeners

12 Listeners

23 Listeners

10 Listeners

16 Listeners